NeuroQure's ASD Insight early autism risk detection test is the first of its kind. The test uses a minimally invasive skin sample to predict the risk for autism in approximately 75% of people who will go on to develop autism.
That means simple identification of risk years earlier than traditional methods, maximizing the chance to engage with therapies and intervening as soon as possible before many developmental milestones have passed.
NeuroQure is bridging the gap and paving the way for improved outcomes and personalized care in autism spectrum disorders at an earlier age than ever.
By bridging the gap between markers and early intervention, NeuroQure is paving the way for improved outcomes and personalized care in autism spectrum disorders.
Tissue sample or discarded foreskin
Tissue sent to NeuroQure's Lab
Cultured tissues analyzed using patented technique
Results delivered in weeks
Earliest Detection: Identify autism risk as soon as days after birth.
High Accuracy: Up to 75% likelihood in detecting autism risk.
Non-Invasive: Uses a minimally invasive skin biopsy.
Rapid Results: Get answers within days, not years.
Actionable Insights: Gain insights to tailor intervention plans.
Our first-of-its-kind early ASD Insight autism risk detection test uses a small skin sample to predict the risk of autism with up to 75% accuracy.
By providing the opportunity to reduce time to diagnosis, NeuroQure enables parents and healthcare providers to implement safe, tailored infant stimulation treatment plans promptly, potentially altering the course of a child's development for the better.
Get started with NeuroQure's ASD Insight autism risk test today.